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Edited by Hans-Dieter KlenkAbstract The 90 kDa ribosomal S6 kinases (p90RSKs) are a
family of broadly expressed serine/threonine kinases with two ki-
nase domains activated by extracellular signal-regulated protein
kinase in response to many growth factors. Our recent study
demonstrated that severe acute respiratory syndrome (SARS)-
coronavirus (CoV) infection of monkey kidney Vero E6 cells
induces phosphorylation and dephosphorylation of signaling
pathways, resulting in apoptosis. In the present study, we inves-
tigated the phosphorylation status of p90RSK, which is a well-
known substrate of these signaling pathways, in SARS-CoV-in-
fected cells. Vero E6 mainly expressed p90RSK1 and showed
weak expression of p90RSK2. In the absence of viral infection,
Ser221 in the N-terminal kinase domain was phosphorylated
constitutively, whereas both Thr573 in the C-terminal kinase do-
main and Ser380 between the two kinase domains were not phos-
phorylated in conﬂuent cells. Ser380, which has been reported to
be involved in autophosphorylation by activation of the C-termi-
nal kinase domain, was phosphorylated in conﬂuent SARS-CoV-
infected cells, and this phosphorylation was inhibited by
SB203580, which is an inhibitor of p38 mitogen-activated protein
kinases (MAPK). Phosphorylation of Thr573 was not upregu-
lated in SARS-CoV-infected cells. Thus, in virus-infected cells,
phosphorylation of Thr573 was not necessary to induce phos-
phorylation of Ser380. On the other hand, Both Thr573 and
Ser380 were phosphorylated by treatment with epidermal growth
factor (EGF) in the absence of p38 MAPK activation. Ser220
was constitutively phosphorylated despite infection. These results
indicated that phosphorylation status of p90RSK by SARS-CoV
infection is diﬀerent from that by stimulation of EGF. This is the
ﬁrst detailed report regarding regulation of p90RSK phosphory-
lation by virus infection.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The signaling pathway of extracellular signal-regulated ki-
nase (ERK) regulates cellular processes, including growth, cell
proliferation, survival, and motility [1]. The p90 ribosomal S6
kinases (RSK), a family of serine/threonine kinases, are impor-*Corresponding author. Fax: +81 42 564 4881.
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doi:10.1016/j.febslet.2006.01.066tant substrates of ERK [2]. The RSK family consists of four
isoforms (RSK1, 2, 3, and 4) and two structurally related
RSK-like protein kinases (RLPK/MSK1) and RSK-B
(MSK2) in humans [2–5]. Members of the RSK family contain
two distinct kinase domains. The C-terminal kinase domain is
thought to be involved in autophosphorylation at the critical
step in 90 kDa ribosomal S6 kinase (p90RSK) activation
[6–8]. On the other hand, the N-terminal kinase domain is
capable of phosphorylation of substrates. Recent studies have
clariﬁed the mechanisms of activation of p90RSK. p90RSK1 is
phosphorylated at Thr573 in the activation loop of the C-ter-
minal kinase domain by ERK because the C-terminal of
p90RSK has an ERK docking site [9,10]. Autophosphoryla-
tion at Ser380 in the linker region is thought to be induced
by activation of the C-terminal kinase domain [11], and then
PDK1 phosphorylates at Ser221 in the activation loop of the
N-terminal kinase domain [12–14].
p90RSK is thought to have multiple functions. In quiescent
cells, p90RSK is present in the cytoplasm, and p90RSK acti-
vated via the ERK signaling pathway by growth factors is im-
ported into the nucleus. p90RSK activates nuclear factor-jB
by phosphorylation of Ij-B and phosphorylates the transcrip-
tion factors, c-Fos and cAMP-response element-binding pro-
tein (CREB) [2]. It has been shown that p90RSK plays
important roles in apoptosis and the cell cycle. p90RSK phos-
phorylates Bad [15,16] and C/EBPb [17], which protects cells
against apoptosis. Furthermore, p90RSK phosphorylates and
inhibits Myt1, which is a p34cdc2 inhibitory kinase, resulting
in G2 arrest in Xenopus extracts [18,19]. In mouse oocytes,
Emi1 and p90RSK2 cooperate to induce metaphase arrest
[20]. p90RSK also functions as a serum-stimulated Na+/H+ ex-
changer-1 kinase and regulates its activity [21]. Recently, it has
been shown that p90RSK activation induces H2O2-mediated
cardiac troponin I phosphorylation, which depresses the
acto-myosin interaction and is important during the progres-
sion of heart failure [21]. Thus, p90RSK has been demon-
strated to play key roles in regulating cellular functions in
the ERK signaling pathway in vitro and in vivo.
Severe acute respiratory syndrome (SARS) is a newly discov-
ered infectious disease caused by a novel coronavirus, SARS
coronavirus (SARS-CoV) [22,23], which spread to more than
30 countries in late 2002, causing severe outbreaks of atypical
pneumonia. Our recent studies using the monkey kidney cell
line, Vero E6, demonstrated that a variety of signaling path-
ways are activated upon infection with SARS-CoV. Especially,
p38 mitogen-activated protein kinase (MAPK) is thought to be
involved in induction of apoptosis because a p38 inhibitor wasblished by Elsevier B.V. All rights reserved.
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CoV infection [24]. Signal transducer and activator of tran-
scription (STAT)-3, which is ordinarily phosphorylated at a
tyrosine residue, is dephosphorylated by SARS-CoV-induced
activation of p38 [25]. c-Jun N-terminal protein kinase
(JNK) and Akt are important for establishing persistent
SARS-CoV infection [26]. In conﬂuent virus-infected cells,
Akt is ﬁrst phosphorylated at a single serine residue shortly
after SARS-CoV infection, and subsequently dephosphoryl-
ated during the course of viral infection [27], whereas Akt,
which is ordinary phosphorylated at a serine residue, was
dephosphorylated by SARS-CoV infection without any upreg-
ulation of its phosphorylation in subconﬂuent cells [28]. This
downregulation of Akt phosphorylation induces inhibition of
cell proliferation by SARS-CoV infection and weak activation
of Akt cannot induce escape from SARS-CoV-induced apop-
tosis. Nucleocapsid protein, X1 and spike proteins of SARS-
CoV are able to induce apoptosis in their expressing cells
[29–32]. Especially, N protein is able to upregulation of phos-
phorylation of JNK and p38 MAPK, but not ERK and Akt
[29]. Although ERK was shown to be phosphorylated in
SARS-CoV-infected cells [25], the function is not clear.
p90RSK is a well-known substrate for ERK as described
above.
In the present study, we showed that Ser380 of p90RSK,
which is thought to be auto-phosphorylated after activation
of the C-terminal kinase domain, is phosphorylated without
upregulation of Thr573 phosphorylation in the C-terminal ki-
nase domain, in SARS-CoV-infected Vero E6 cells. Further-
more, we demonstrated that activation of p38 MAPK was
responsible for phosphorylation of Ser380 in virus-infected
cells. These results indicated signaling pathways, which are dif-
ferent from those induced by growth factor, contribute to
phosphorylation of p90RSK in SARS-CoV-infected cells.2. Materials and methods
2.1. Cells and virus
Vero E6 cells were subcultured routinely in 75-cm3 ﬂasks in Dul-
becco’s modiﬁed Eagle’s medium (DMEM; Sigma, St. Louis, MO,
USA) supplemented with 0.2 mM L-glutamine, 100 units/ml penicillin,
100 lg/ml streptomycin, and 5% (v/v) fetal bovine serum (FBS), and
maintained at 37 C in an atmosphere of 5% CO2. For use in the exper-
iments, the cells were split once onto 6- and 24-well tissue culture plate
inserts and cultured under subconﬂuent and conﬂuent conditions.
SARS-CoV, which was isolated as Frankfurt 1 and kindly provided
by Dr. J. Ziebuhr, was used in the present study. Infection was usually
performed at a multiplicity of infection (m.o.i.) of 10. The number
of cells was counted using the WST-1 cell proliferation assay system
(Takara, Shiga, Japan).
2.2. Inhibitor
The p38 MAPK inhibitor, SB203580, which was purchased from
Calbiochem (La Jolla, CA, USA), was dissolved in dimethyl sulfoxide
(DMSO) at a concentration of 10 mM. The same volume of DMSO
alone was used as a control. As shown in previous reports [24,27],
SB203580 and PD98059 had no eﬀect on viral replication including vir-
al protein synthesis.
2.3. Western blotting
The whole-cell extracts were electrophoresed on 5–20% gradient
polyacrylamide gels, and transferred electrophoretically onto PVDF
membranes (Immobilon-P; Millipore, Bedford, MA, USA). In the
present study, we applied two sets of samples to polyacrylamide gels,
and the membranes were divided into two halves after blotting usinga LumiGLO Elite chemiluminescent system (Kirkegaard and Perry
Laboratories, Gaithersburg, ML, USA). When it was necessary to
strip the membranes, Restore Western blot stripping buﬀer (Pierce,
Rockford, IL, USA) was used. The following antibodies, obtained
from Cell Signaling Technology Inc. (Beverly, MA, USA), were used
in the present study at a dilution of 1:1000: rabbit anti-phospho Akt
(Ser473) antibody, rabbit anti-Akt antibody, rabbit anti-phospho-
PDK1 (Ser241) antibody, rabbit anti-phospho STAT3 (Tyr-705)
antibody, rabbit anti-p38 MAPK (Thr180/Tyr182) antibody, rabbit anti-
p38 MAPK antibody, rabbit anti-phospho-ERK1/2 (Thr202/Tyr204)
antibody, rabbit anti-ERK antibody, rabbit anti-phospho-MEK1/2
(Ser217/221) antibody, rabbit anti-MEK1/2 antibody, rabbit anti-
p90RSK1/2/3 antibody, rabbit anti-cleaved Caspase-3 (Asp175) anti-
body, rabbit anti-cleaved Caspase-7 (Asp198) antibody. Rabbit Mouse
anti-STAT3 antibody (diluted 1:2500) was obtained from BD Biosci-
ences (Franklin Lakes, NJ, USA). Rabbit anti-p90RSK1 monoclonal
antibody, which was purchased from Epitomics, Inc. (Burlingame,
CA, USA), was diluted at 1:1000. Rabbit anti-p90RSK2 (C-term),
p90RSK3 (Mid) and p90RSK4 (N-term) were purchased from Zymed
Laboratory, Inc. (South San Francisco, CA, USA). Anti-p90RSK2
and 4 antibodies were diluted 1:250, and anti-p90RSK3 was diluted
1:500. Rabbit anti-PARP p85 fragment antibody was purchased from
Promega (Madison, WI, USA) and diluted 1:100. Mouse anti-b-actin
antibody was purchased from Sigma (St. Louis, MO, USA) and used
at a dilution of 1:5000. Rabbit anti-SARS N and M antibodies were
described previously [24]. K562 and Jurkat cell lysates were purchased
from Clontech Laboratories Inc. (Mountain View, CA, USA).3. Results
3.1. Signaling pathways in SARS-CoV-sensitive cell lines
As shown in Fig. 1, SARS-CoV-infected conﬂuent Vero E6
cells induced phosphorylation or dephosphorylation of signal-
ing pathways as also described in previous studies [24,27,28].
The cytopathic eﬀects (CPEs) were observed in Vero E6 cells
at 24-h post-infection (h.p.i.). DNA fragmentation as an indi-
cator of apoptosis was detected at 24 h.p.i. [24]. Among the
signaling pathways activated by SARS-CoV infection, p38
MAPK is thought to act as a pro-apoptotic signaling pathway,
whereas Akt has an anti-apoptotic eﬀect. Vero cells, the paren-
tal cells of Vero E6, are also sensitive to SARS-CoV infection.
However, the time point of the appearance of CPE on Vero
cells by SARS-CoV infection is later than that of Vero E6 cells
at 24 h.p.i. (data not shown). As shown in Fig. 1A, nucleocap-
sid (N) protein of SARS-CoV was detected at 17 h.p.i. in both
cell lines. The level of N protein in Vero cells was only slightly
lower than that in Vero E6 cells, indicating that replication of
SARS-CoV is not markedly diﬀerent between the two cell
lines. Anti-apoptotic Akt was phosphorylated at 17 h.p.i. in
both cell lines, and was dephosphorylated at 27 h.p.i.
(Fig. 1B). Our previous study indicated that phosphorylation
level of Akt around 17 h.p.i. is only 20% of phosphorylated
Akt in growing cells [28]. Therefore, this low level of activation
cannot prevent apoptosis by SARS-CoV infection. Fig. 1B
also shows that ERK was phosphorylated at 17 h.p.i. in both
cell lines, similar to the observations regarding Akt. The apop-
totic markers, PARP (p85) and cleaved caspase-3 and -7, were
detected in Vero E6 and Vero cells at 27 and 44 h.p.i., respec-
tively (Fig. 1A). The p38 MAPK in virus-infected Vero E6 and
Vero cells was phosphorylated at 17 and 27 h.p.i., respectively
(Fig. 1A). Tyrosine of STAT3 was also dephosphorylated via
phosphorylation of p38 MAPK as reported previously [25].
Thus, SARS-CoV-induced apoptosis related to time-depen-
dent activation of the pro-apoptotic signaling pathway, p38
MAPK. Taken together, these results suggested that substrates
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Fig. 1. Phosphorylation of signaling pathways in SARS-CoV-infected
cells. Vero and Vero E6 cells were prepared at conﬂuence in 24-well
plates and the cells were infected with SARS-CoV at 10 m.o.i. Protein
samples were obtained at 17, 24, and 44 h.p.i. The protein of Vero E6
cells at 44 h.p.i. could not be obtained due to strong morphological
changes caused by apoptosis. Western blotting analyses were per-
formed to examine signaling pathways (A) and apoptotic marker
proteins (B).
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Fig. 2. p90RSK family expressed in Vero E6 cells. Vero E6 cells were
prepared at densities of 1 · 106 and 0.6 · 105 in 6-well plates. HeLa
cells, a clonal cell line for another study, were used as controls. Both
K562 and Jurkat cell lysates were obtained from Clontech Laborato-
ries Inc. Western blotting analysis was performed using the same
amounts of protein. According to the antibody product data sheets,
anti-human p90RSK1 monoclonal antibody (Epitomics) does not
cross-react with other RSK family members. Anti-human and mouse
p90RSK2 antibody (Zymed) does not react with overexpressed
p90RSK1, 3, or 4. Anti-human p90RSK3 antibody (Zymed) does
not react with overexpressed p90RSK1, 2, or 4. Anti-human p90RSK
antibody (Zymed) does not react with p90RSK1, 2, or 3. Anti-
p90RSK1/2/3 antibody (Cell Signaling) detects endogenous levels of
RSK1, RSK2, and RSK3 proteins. In Vero E6 cells, the band of RSK1
was stronger than that of RSK2 as described in the text. The weak
bands were enhanced using Adobe Photoshop.
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understanding the cytopathic eﬀects of SARS-CoV infection.
3.2. Phosphorylation of p90RSK Ser221 in Vero E6 cells
p90RSK is phosphorylated by both PDK-1 and ERK
[2,13,14]. Ser221 of p90RSK1 is phosphorylated by PDK-1
and Thr359, Ser363, and Thr573 of p90RSK-1 are phosphor-
ylated by ERK. p90RSK is thought to play important roles
in apoptosis and the cell cycle. Both PI3K/Akt and ERK sig-
naling pathways are activated early post-infection with
SARS-CoV in both Vero and Vero E6 cells (Fig. 1B). There-
fore, p90RSK may be a target of both signaling pathways in
SARS-CoV-infected cells. At least four species of p90RSK
(p90RSK1, 2, 3, and 4) has been reported to date [2–5]. We
used anti-p90RSK antibodies, which do not cross-react with
other p90RSK family members, as described in the legend of
Fig. 2. We measured densities of RSK1 and 2 bands in Vero
E6 cells using LAS-3000 mini system (Fuji Photo Film Co.Ltd, Tokyo, Japan). The amount of p90RSK1 in subconﬂuent
cells, p90RSK2 in conﬂuent cells and p90RSK2 in subconﬂu-
ent cells were 73.05%, 39.94% and 14.70% of RSK1 in conﬂu-
ent cells, respectively. Although aﬃnity of each antibody is
diﬀerent, this result suggested that p90RSK1 was expressed
stronger than p90RSK2 in Vero E6 cells. p90RSK1 is ex-
pressed mainly in the human kidney, lung, and pancreas,
whereas p90RSK2 is expressed in skeletal muscle, heart, and
pancreas [33]. p90RSK3 and 4 were not detected in Vero E6
and HeLa cells in the present study. The p90RSK4 was weakly
detected in K562 and Jurkat cells.
We examined the phosphorylation status of p90RSK Ser221
in Vero E6 cells. Our previous study indicated that very low
levels of Akt in conﬂuent Vero E6 cells are phosphorylated
at serine, whereas the level is high in subconﬂuent cells [28].
However, the phosphorylated threonine of Akt is diﬃcult to
detect in subconﬂuent Vero E6 cells. We only detected it
weakly when the cells were treated with epidermal growth fac-
tor (EGF) at 1 min [28]. As threonine of Akt was transiently
phosphorylated by EGF treatment, it was never detected after
5 min. On the other hand, serine of Akt was easily phosphor-
ylated by treatment with EGF after 3 min. The threonine res-
idue of Akt is phosphorylated by PDK-1, and the serine
residue of Akt is thought to be phosphorylated by the putative
kinase, PDK-2. To compare the phosphorylation level of
PDK-1 at diﬀerent cell densities, Vero E6 cells were prepared
at 10, 5, 2.5, 1.25, 0.6, and 0.3 · 105 cells in 5% FBS containing
DMEM per well in 6-well plates. At a density of 10 · 105 cells,
Vero E6 cells showed 100% conﬂuence in this experiment. As
shown in Fig. 3A, the level of PDK-1 phosphorylation was
similar at all cell densities. Ser221 of p90RSK was also phos-
phorylated at a similar level. The conﬂuency of Vero E6 cells
in the present study is shown in Fig. 3B. To conﬁrm that the
Fig. 3. Phosphorylation of p90RSK Ser221 in Vero E6 cells. (A) Vero E6 cells were prepared at densities of 10, 5, 2.5, 1.25, 0.6, and 0.3 · 105 cells in
DMEM containing 5% FBS per well in 6-well plates. Proteins were obtained from these cells after 24 h, and Western blotting was performed using
anti-phospho p90RSK (Ser221). (B) The conﬂuency of Vero E6 cells used in this study is shown. (C) 2 · 103 cells in DMEM containing 0.2% and 5%
FBS were prepared in 96-well plates. After 4 days, cell number was counted using a WST-1 cell proliferation assay kit. (D) 0.25 and 10 · 105 cells in
DMEM containing various concentrations of FBS were prepared in 6-well plates. Western blotting was performed using proteins obtained after 24 h.
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unaﬀected by cell proliferation, Vero E6 cells were cultured
in medium containing low and high concentrations of FBS.
Cell proliferation of Vero E6 cells was partially suppressed
in medium containing 0.2% FBS as compared with 5% FBS
(Fig. 3C). Conﬂuent and subconﬂuent cells in medium contain-
ing 5–0.2% FBS showed similar phosphorylation levels of
PDK-1 and p90RSK at Ser221 (Fig. 3D). Thus, the phosphor-
ylation level of Ser221 of p90RSK is not inﬂuenced by the sta-
tus of cell proliferation.3.3. Phosphorylation of p90RSK Ser380 and Thr573 in Vero E6
cells
p90RSK1 is phosphorylated at Thr573 in the activation loop
of the C-terminal kinase domain [9,10], and this activation of
the C-terminal kinase domain is thought to lead to autophos-
phorylation at Ser380 [11]. Activation of the C-terminal do-
main by the ERK signaling pathway is thought to be
necessary for phosphorylation at Ser380 [34]. Fig. 4A indicates
that EGF treatment induces phosphorylation of ERK in Vero
E6 cells. Both Thr573 and Ser380 of p90RSK were phosphor-
T. Mizutani et al. / FEBS Letters 580 (2006) 1417–1424 1421ylated early after EGF treatment. Interestingly, the phosphor-
ylation level of p90RSK Ser221 was not altered by EGF treat-
ment. To investigate whether cell density aﬀects
phosphorylation level of p90RSK Thr573 and Ser380, Western
blotting analysis was performed using proteins obtained from
10, 5, 2.5, 1.25, 0.6, and 0.3 · 105 cells in DMEM containing
5% FBS per well in 6-well plates. Fig. 4B shows that Ser380
of p90RSK phosphorylation was increased by decreasing cell
density. Although Thr573 was also increased phosphorylation
by decreasing cell density, the amount was very low. The
amount of Thr573 phosphorylated p90RSK in 0.3 · 105 cells
is only 11.53% of Ser380 using LAS-3000 mini system. There-
fore, the band of Thr573 phosphorylated p90RSK was diﬃcult
to see in Fig. 4B.
3.4. Phosphorylation of p90RSK in SARS-CoV-infected cells
To investigate regulation of p90RSK phosphorylation in
SARS-CoV-infected cells, conﬂuent Vero E6 cells were in-
fected with SARS-CoV at approximately 50 m.o.i., and Wes-
tern blotting analysis was performed using proteins at 26 and
24 h.p.i. As shown in Fig. 5A, no signiﬁcant diﬀerences in
phosphorylation levels of PDK-1 or p90RSK at Ser221 were
observed between conﬂuent virus-infected cells at 16 and
24 h.p.i. Phosphorylation of Thr573 was not upregulated by
viral infection. Ser380 of p90RSK is phosphorylated in virus-
infected conﬂuent cells. Previous reports indicated autophos-
phorylation of Ser380 after activation of C-terminal kinase
domain [11]. Thus, phosphorylation of p90RSK Ser380 is
upregulated without upregulation of Thr573 in SARS-CoV-
infected cells.emtaert-FGE
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Fig. 4. Phosphorylation of p90RSK Thr573 and Ser380 in Vero E6 cells. Co
blotting analysis was performed using proteins obtained at 0, 1, 5, and 10 m
0.3 · 105 cells in 6-well plates. Proteins were obtained from these cells after 2
(Thr573 and Ser380). The proteins used in (B) were the same as those in Fig3.5. Phosphorylation of p90RSK Ser380 under ERK and p38
MAPK signaling pathways
These observations raise a question regarding which signal-
ing pathway regulates phosphorylation of Ser380 of p90RSK
in SARS-CoV-infected cells. p90RSK is thought to act in re-
sponse to stimulation and p38 MAPK plays key roles in cyto-
pathic eﬀects in SARS-CoV-infected cells, as shown in Fig. 1
and in our previous study [24]. As shown in Fig. 5A, Ser380
was phosphorylated without phosphorylation of Thr573 in
virus-infected cells, suggesting that the ERK signaling pathway
is not important for phosphorylation of Ser380. We next inves-
tigated whether p38 MAPK inhibitor can inhibit phosphoryla-
tion of Ser380. Conﬂuent cells were prepared in 24-well plates.
Cells were infected with SARS-CoV for 1 h, and then
SB203580 was added as a p38 MAPK inhibitor. Western blot-
ting analysis was performed using proteins at 24 h.p.i. As
shown in Fig. 5B, phosphorylation of Ser380 was decreased
in SB203580-treated cells.4. Discussion
In the present study, we showed that p90RSK, the best-
known substrate of ERK and PDK-1, was regulated phos-
phorylation in SARS-CoV-infected Vero E6 cells. There has
been one previous report regarding phosphorylation of
p90RSK by viral infection. Rous sarcoma virus has the ability
to phosphorylate p90RSK [35], but there have been no de-
tailed analyses of p90RSK phosphorylation. Investigation of
the phosphorylation status of p90RSK by viral infection istn
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cells were treated with DMSO as a control.
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apoptosis.
Thr573 of p90RSK in mock infected cells was phosphory-
lated by EGF stimulation (Fig. 4A). The Thr573 was slightly
phosphorylated in subconﬂuent mock infected cells compared
with conﬂuent mock infected cells (Fig. 4B). However, the
phosphorylation was decreased by SARS-CoV-infection and
was abolished by the MEK1/2-speciﬁc inhibitor, PD98059
(data not shown). Therefore, the ERK signaling pathway is in-
volved in phosphorylation of Thr573 in Vero E6 cells. These
observations raise a question regarding the role of ERK in
SARS-CoV-infected cells. PD98059-treated SARS-CoV-in-
fected Vero E6 cells showed no signiﬁcant changes in activated
caspase-3 or -7 at 18 h.p.i. (data not shown). This result sug-
gested that phosphorylation of ERK was not suﬃcient to pre-
vent apoptosis by SARS-CoV infection, as discussed
previously regarding the lack of an inhibitory eﬀect on apopto-
sis due to low activation of Akt in virus-infected cells [27]. Fur-
thermore, we found diﬀerent phosphorylation kinetics between
ERK1 and ERK2 in EGF-treated and SARS-CoV-infected
cells. Interestingly, the phosphorylation level of ERK1 is sim-
ilar to that of ERK2 in SARS-CoV-infected Vero E6 cells
(Fig. 1B). Among several experiments, the phosphorylation le-
vel of ERK1 was sometimes higher than that of ERK2, as in
the case of virus-infected Vero cells at 27 and 44 h.p.i.
(Fig. 1B). The total amounts of ERK1 were lower than those
of total ERK2 in both mock- and SARS-CoV-infected cells.
To conﬁrm that factors contained in seed virus do not upreg-
ulate phosphorylation of ERK1, SARS-CoV in seed virus was
completely neutralized by anti-SARS-CoV antibody, and then
added to cells, resulting in no upregulation of the phosphory-
lation of ERK1/2 (data not shown). Thus, the strong phos-phorylation of ERK1 occurred speciﬁcally in SARS-CoV-
infected cells. In the case of EGF stimulation, the phosphory-
lation level of ERK1 was lower than that of ERK2 (Fig. 4A).
Eblen et al. showed that ERK2 phosphorylates p90RSK [34].
Angenstein et al. identiﬁed p90RSK, ERK2, and GSK-3b as
poly-associated proteins, suggesting that polyribosome-bound
ERK2 activates p90RSK, and then inhibits GSK-3b [36].
Thus, ERK2 activation is important for phosphorylation of
p90RSK in the absence of viral infection. On the other hand,
the strong phoshorylation of ERK1 in SARS-CoV-infected
cells may aﬀect on phosphorylation status of p90RSK as dis-
cussed below.
p90RSK is phosphorylated at Thr573 in the activation loop
of the C-terminal kinase domain, and then autophosphoryla-
tion at Ser380 in the linker region is thought to be led by this
C-terminal kinase domain [11,40]. The phosphorylation level
of Ser380 in conﬂuent Vero E6 cells was very low, and
SARS-CoV infection induced phosphorylation of Ser380
(Fig. 5). However, as described above, upregulation of
Thr573 was not observed in virus-infected cells. There may
be diﬀerences in regulation of Ser380 in SARS-CoV-infected
cells from other stimuli. In the present study, we showed that
p38 MAPK can induce phosphorylation of Ser380. Several re-
ports have suggested that p90RSK activation results in phos-
phorylation of CREB [2,41]. Our previous study showed that
SARS-CoV infection of Vero E6 cells induces phosphorylation
of CREB, and treatment with SB203580 can inhibit this phos-
phorylation [24]. Thus, phosphorylation of CREB is regulated
by p38 MAPK in SARS-CoV-infected cells. In addition, phos-
phorylation of ERKs was partially downregulated by treat-
ment with SB203580 in virus-infected cells in viral infected
cells (data not shown). Although there is a possibility of
T. Mizutani et al. / FEBS Letters 580 (2006) 1417–1424 1423nonspeciﬁc reaction by SB203580, cross-talk between ERK
and p38 has been reported [37–39]. On the other hand, EGF
stimulation induces phosphorylation of ERK without phos-
phorylation of p38 MAPK (Fig. 4A). Several signaling path-
ways of p38 MAPK and ERKs including cross-talk may
exist in Vero E6 cells. These results may indicate a signaling
cascade, p38 MAPK > (ERK >) p90RSK > CREB, in virus-
infected cells. Further investigations are necessary to clarify
the roles of p90RSK in virus-infected cells.
Based on these results, we conclude that phosphorylation of
p90RSK Ser380 is regulated by p38 MAPK, in the absence of
upregulation of Thr573 phosphorylation in SARS-CoV-in-
fected cells. These new observations provide valuable insights
into the biological eﬀects of p90RSK in SARS-CoV infection.
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